Chun-Eng Liu
Overview
Explore the profile of Chun-Eng Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
880
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Liu C, Wang W, Tan M, Chen P, Shiau Y, et al.
J Microbiol Immunol Infect
. 2025 Feb;
PMID: 39934015
Background: To determine susceptibility of imipenem-non-susceptible Escherichia coli (INS-EC) and Klebsiella pneumoniae (INS-KP) isolates collected during 2020-2022 through a national surveillance program in Taiwan to novel antibiotics, and to compare...
2.
Esser S, Inciarte A, Levy I, Monforte A, Lambert J, van Welzen B, et al.
Future Microbiol
. 2024 Sep;
19(15):1273-1282.
PMID: 39229785
What Is This Summary About?: This is a summary of an article about an ongoing study called the BICSTaR study.The BICSTaR study includes people with HIV (human immunodeficiency virus) who...
3.
Lee Y, Liu C, Tang H, Huang Y, Chen Y, Hsueh P
J Microbiol Immunol Infect
. 2024 Apr;
57(3):446-456.
PMID: 38632023
Background: The coronavirus disease 2019 (COVID-19) pandemic has contributed to the spread of antimicrobial resistance, including carbapenem-resistant Enterobacterales. Methods: This study utilized data from the Study for Monitoring Antimicrobial Resistance...
4.
Huang Y, Yang C, Sun H, Lee C, Lu P, Tang H, et al.
Int J Infect Dis
. 2024 Jan;
140:1-8.
PMID: 38163618
Objectives: WHO has recommended same-day antiretroviral therapy (SDART) initiation since 2017; however, higher attrition rates were noted in developing countries. Methods: We included newly diagnosed people with HIV (PWH) from...
5.
Esser S, Brunetta J, Inciarte A, Levy I, Monforte A, Lambert J, et al.
HIV Med
. 2023 Dec;
25(4):440-453.
PMID: 38148567
Background: Real-world evidence is an essential component of evidence-based medicine. The aim of the BICSTaR (BICtegravir Single Tablet Regimen) study is to assess effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF)...
6.
Lee Y, Liu C, Ko W, Hsueh P
Int J Antimicrob Agents
. 2023 Jun;
62(2):106878.
PMID: 37285926
Stenotrophomonas maltophilia is an emerging opportunistic pathogen for which there are limited therapeutic options because of intrinsic multidrug resistance. S. maltophilia isolates were collected as part of the Antimicrobial Testing...
7.
Su W, Yang C, Chang R, Yeh Y, Yen H, Yang C, et al.
J Infect Public Health
. 2023 Jun;
16(8):1201-1208.
PMID: 37271101
Background: Treating marginalized populations with HCV infection for elimination is faced with the challenge for the integration of HCV screening service offered for patients often moving across multiple settings. We...
8.
Huang Y, Cheng C, Sun H, Cheng S, Lu P, Lee C, et al.
Microbiol Spectr
. 2023 Mar;
11(3):e0512522.
PMID: 36988457
Data regarding the durability of tenofovir alafenamide (TAF)-containing antiretroviral therapy (ART) in maintaining hepatitis B virus (HBV) viral suppression among HIV/HBV-coinfected patients are limited. Between February and October 2018, 274...
9.
Tsai M, Sun H, Chen C, Lee C, Lee C, Liu C, et al.
Int J Infect Dis
. 2022 Nov;
126:39-47.
PMID: 36384186
Objectives: Real-world experience with coformulated bictegravir, emtricitabine, and tenofovir alafenamide (BIC/FTC/TAF) is sparse as a switch regimen among people living with HIV (PLWH) having achieved viral suppression after previous virologic...
10.
Chong C, Liu C, Leong Y, Liao S, Lai H, Lee Y
J Microbiol Immunol Infect
. 2022 Oct;
56(2):274-281.
PMID: 36243667
Background: Healthcare workers (HCWs) without evidence of immunity to varicella-zoster virus (VZV) are recommended to undergo varicella vaccination. Immunogenicity of live attenuated varicella vaccine has rarely been investigated among HCWs...